M Ventures' managing directors Hakan Goker and Owen Lozman explore the future of biotech and frontier technology.

Hakan Goker and Owen Lozman are the managing directors of M Ventures, the CVC of German technology company Merck Group, and respectively oversee the unit’s activity in biotech on one hand and electronics and frontier technology on the other.
Innovation is moving fast across most sectors, but in healthcare, technology is tantalisingly close to solving some of the most enduring health problems.
We ...

Want to read this article?

Subscribe to GCV+

or login to your account

Fernando Moncada Rivera

Fernando Moncada Rivera is a reporter at Global Corporate Venturing and also host of the CVC Unplugged podcast.